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E V I D E N C E - B A S E D A N S W E R
Persistent treatment with topical/intralesional
therapy should continue to be the mainstay
Verruca vulgaris (the common wart) is frequently
encountered by the family physician, often after
unsuccessful topical treatment. Unfortunately, 
evidence is insufficient to warrant routine use of
oral agents such as cimetidine, zinc, or levamisole
in the treatment of refractory lesions. The added
cost and potential side effects of proposed oral
treatments isn’t justified until more rigorous studies
show clear clinical efficacy. Persistent treatment
with proven topical and intralesional therapy 
for refractory lesions should continue to be the 
mainstay of therapy for verruca vulgaris.
Christopher P. Paulson, MD
US Air Force Family Medicine Residency, 
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Of the available oral therapies for common warts,
none has sufficient evidence to recommend it as
an effective therapy (strength of recommendation
[SOR]: B). To date, no oral agent has been shown
to be effective in a randomized, placebo-
controlled, double-blinded trial. Very limited 
evidence is emerging that zinc may be 
effective (SOR: C).
C L I N I C A L C O M M E N T A R Y
n Evidence summary
Oral therapies for common warts suffer
from a lack rigorous clinical data regard-
ing their efficacy. A detailed literature
search found multiple trials evaluating
various oral agents. However, only 6 trials
met the selection criteria of randomized,
controlled trials published in English. 
Cimetidine (Tagamet) has been 
compared with placebo in 3 trials1–3 and
was not found superior to placebo.
Levamisole (Ergamisol), used in combi-
nation with cimetidine, has been com-
pared with cimetidine alone in 2 trials,4,5
and was found to be effective at speeding
regression of warts, with patients in the
combination arm showing a mean regres-
sion time of 7.8 weeks compared with 
11 weeks in the cimetidine alone group.
These small studies involved 48 and 
44 patients, respectively. In addition, 1
nonrandomized controlled trial6 found
levamisole at 5 mg/kg for 3 days every 2
weeks to be superior to placebo in
achieving complete cure of warts in a
group of 40 patients.
Zinc is the only agent to demonstrate
efficacy in a completely randomized and
placebo-controlled study.7 However, this
trial was unblinded, had only 40 subjects
assigned to each agent, had a dropout
rate of 46%, and did not follow inten-
tion-to-treat analysis. 
Recommendations from others 
Clinical Evidence lists cimetidine and lev-
amisole as therapies of unknown effec-
tiveness.8 The commentary on both
agents notes that the size of each ran-
domized controlled trial cited may have
been too small to detect clinically impor-
tant differences.
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CLINICAL INQUIRIES
FAST TRACK
No oral 
medications 
have been shown
to be an effective
treatment for 
common warts,
but clinical data 
are not rigorous
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